Status: current, Defined. Date: 31-Jul 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1661761000168110 | lanreotide 120 mg / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1661771000168116 | lanreotide 120 mg/0.5 mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lanreotide 120 mg/0.5 mL injection, syringe | Is a | lanreotide | true | Inferred relationship | Some | ||
| lanreotide 120 mg/0.5 mL injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| lanreotide 120 mg/0.5 mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| lanreotide 120 mg/0.5 mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 1870690911 | |
| lanreotide 120 mg/0.5 mL injection, syringe | has Australian BoSS | lanreotide | true | Inferred relationship | Some | 1870690910 | |
| lanreotide 120 mg/0.5 mL injection, syringe | has intended active ingredient | lanreotide | true | Inferred relationship | Some | 1870690910 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mytolac 120 mg/0.5 mL injection, 0.5 mL syringe | Is a | True | lanreotide 120 mg/0.5 mL injection, syringe | Inferred relationship | Some | |
| lanreotide 120 mg/0.5 mL injection, 0.5 mL syringe | has MPUU | True | lanreotide 120 mg/0.5 mL injection, syringe | Inferred relationship | Some | 1 |
| Somatuline Autogel 120 mg/0.5 mL injection, 0.5 mL syringe | Is a | True | lanreotide 120 mg/0.5 mL injection, syringe | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR